
|Articles|April 17, 2013
Christine Solberg Strahl, PharmD, Discusses the Management of New Drugs on the Medical Benefit
Christine Solberg Strahl, PharmD, Specialty Pharmacy Program Manager, HealthPartners, says that by managing specialty drugs before utilization patterns are established there is less member and provider dissatisfaction.
Advertisement
Christine Solberg Strahl, PharmD, Specialty Pharmacy Program Manager, HealthPartners, says that by managing specialty drugs before utilization patterns are established there is less member and provider dissatisfaction. Using medical injectables as an example, Dr Strahl says that there are coding and pricing issues associated when managing new specialty drugs that are administered on the specialty benefit.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
3
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
4
Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes
5




